Monsanto Co (MON)

102.13
NYSE : Basic Materials
Prev Close 102.13
Day Low/High 0.00 / 0.00
52 Wk Low/High 82.81 / 114.26
Avg Volume 4.23M
Exchange NYSE
Shares Outstanding 437.58M
Market Cap 45.29B
EPS 4.80
P/E Ratio 43.67
Div & Yield 2.16 (2.10%)

Latest News

Oil, Yellen and World GDP Growth: How to Trade the Week Ahead

Oil, Yellen and World GDP Growth: How to Trade the Week Ahead

Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.

Monsanto Announces Global Licensing Agreement With Broad Institute On Key Genome-Editing Application

Monsanto Announces Global Licensing Agreement With Broad Institute On Key Genome-Editing Application

Monsanto Company (NYSE: MON) announced today that it has reached a global licensing agreement for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and Harvard.

Analysts' Actions -- Clovis, Altria, Sketchers, Wells Fargo and More

Analysts' Actions -- Clovis, Altria, Sketchers, Wells Fargo and More

Here are Wednesday's top research calls, including an upgrade for Clovis Oncology, downgrades for Sketchers USA and Wells Fargo and new coverage for Altria.

Monsanto (MON) Stock Higher, Upgraded at JPMorgan

Monsanto (MON) Stock Higher, Upgraded at JPMorgan

Monsanto's (MON) stock rating was increased to 'overweight' at JPMorgan on Wednesday morning.

Bayer Raises Drug Sales Targets and Leaves Monsanto Combination Trailing

Bayer Raises Drug Sales Targets and Leaves Monsanto Combination Trailing

CEO Werner Baumann increases sales and margin forecasts for pharmaceuticals and insists Monsanto deal will deliver growth and improved profit.

Twitter, Intel, Starbucks: Doug Kass' Views

Twitter, Intel, Starbucks: Doug Kass' Views

Doug Kass shares his thoughts on what goes on his best ideas list and what's still moving down.

Monsanto (MON) Stock Declines, Citigroup: Little Choice But to Accept Bayer Offer

Monsanto (MON) Stock Declines, Citigroup: Little Choice But to Accept Bayer Offer

Citigroup analysts say Monsanto (MON) was 'left with little choice' but to accept the Bayer (BAYRY) offer, mostly due to the time value of money.

Bayer, Monsanto Brace for Long Climb With Regulators

Bayer, Monsanto Brace for Long Climb With Regulators

Despite intense opposition from farm groups and skepticism from government enforcers, the merging crop technology giants say they expect to win approval by end of 2017.

Monsanto (MON) Stock Down, Bayer Deal Likely to Face Scrutiny

Monsanto (MON) Stock Down, Bayer Deal Likely to Face Scrutiny

Bayer's (BAYRY) $66 billion all-cash takeover of Monsanto (MON) is expected to generate push back from political and regulatory officials who claim it threatens competition in the farm supplier industry.

Crude Selloff Pulls Stocks Lower but Apple Saves Nasdaq

Crude Selloff Pulls Stocks Lower but Apple Saves Nasdaq

Another selloff on commodity markets on Wednesday contributed to stock losses throughout the day.

Stocks Waver as Oil Tumbles but Apple Lifts Nasdaq

Stocks Waver as Oil Tumbles but Apple Lifts Nasdaq

Stocks lose highs by mid-afternoon Wednesday as a selloff in crude resumes.

4 Big Stocks to Add to Your Buy List -- Plus 3 to Avoid

4 Big Stocks to Add to Your Buy List -- Plus 3 to Avoid

Here's a technical look at how to trade some of the most active stocks on the market right now.

Jim Cramer: I Don't Think Monsanto-Bayer Deal Will Close

Jim Cramer: I Don't Think Monsanto-Bayer Deal Will Close

Jim Cramer says he doesn't think Bayer's proposed acquisition of Monsanto will close.

Monsanto (MON) Stock Up, Bernstein: 50% Chance Bayer Deal Will Close

Monsanto (MON) Stock Up, Bernstein: 50% Chance Bayer Deal Will Close

Bernstein analysts say Monsanto's (MON) $66 billion merger with Bayer (BAYRY) is up against steep antitrust hurdles, resulting in a 50% chance of it being completed.

Monsanto (MON) CEO Grant, Bayer CEO Baumann Discuss $66 Billion Deal

Monsanto (MON) CEO Grant, Bayer CEO Baumann Discuss $66 Billion Deal

The CEOs of Monsanto (MON) and Bayer (BAYRY) joined BloombergTV to discuss their $66 billion combination.

Stocks Add to Gains as Apple Boosts Dow, Crude Fluctuates

Stocks Add to Gains as Apple Boosts Dow, Crude Fluctuates

Stocks add to slight gains on Wednesday as Wall Street stabilizes after three days of extreme swings.

U.S. Stocks Rise Despite Oil Declines; Ford Unveils Growth Plan

U.S. Stocks Rise Despite Oil Declines; Ford Unveils Growth Plan

U.S. stocks gained steam on Wednesday, even though oil prices continued to slide.

Some Investors Expect Monsanto (MON), Bayer Deal to be Blocked

Some Investors Expect Monsanto (MON), Bayer Deal to be Blocked

Bloomberg Executive editor of global deals Jeff McCracken reacts to the deal in which Bayer (BAYRY) will acquire Monsanto (MON) for $66 billion, or $128 per share.

Stock Futures Edge Higher After a Rocky Three Days

Stock Futures Edge Higher After a Rocky Three Days

Stock futures edge higher on Wednesday as Wall Street appears to stabilize after three days of extreme swings.

Bayer and Monsanto Confirm $66 Billion Deal

Bayer and Monsanto Confirm $66 Billion Deal

The agreement values the world's biggest seed maker at $128 per share and comes with a promise of $1.5 billion of annual synergies.

Morning Movers: BAYRY, MON, WFC, JPM, MYL

Morning Movers: BAYRY, MON, WFC, JPM, MYL

Bayer has agreed to purchase Monsanto for $66 billion, or $128 a share, a 20% premium over its previous closing price.

Monsanto (MON) Stock Up, Bayer Purchases for $66 Billion

Monsanto (MON) Stock Up, Bayer Purchases for $66 Billion

Monsanto (MON) agreed to be purchased by Bayer (BAYRY) for $66 billion, or $128 per share, in an all-cash deal.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures point to a slight rebound for Wall Street on Wednesday; report says Bayer to announce acquisition of Monsanto; Wells Fargo CEO John Stumpf says he won't resign.

Bayer Shareholders Unmoved by Reported $66 Billion Monsanto Deal

Bayer Shareholders Unmoved by Reported $66 Billion Monsanto Deal

Monsanto shares should rise if the $129-per-share deal, including a massive break fee, is confirmed, while Bayer investors appear unsure whether to celebrate or mourn.

Futures Shake Rate Fears, Point Higher as Asia Opens Mixed

Futures Shake Rate Fears, Point Higher as Asia Opens Mixed

Futures point toward a higher open Wednesday after strong drops Tuesday amid rate jitters and lower oil.

Monsanto (MON) Stock Lower, Bayer Again Raises Bid

Monsanto (MON) Stock Lower, Bayer Again Raises Bid

Bayer is upping its bid for Monsanto (MON), this time to $129 per share, according to Bloomberg.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: NILE, NL, UGP, YUME Downgrades: AIRT, ASM, BFS, ETP, FNV, GCAP, JNP, MON, TEDU Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Monsanto (MON) Stock Lower, Board to Decide on Bayer Deal

Monsanto (MON) Stock Lower, Board to Decide on Bayer Deal

Monsanto's (MON) board could decide on the proposed acquisition by Bayer (BAYRY) today, sources told Reuters.